KLK3 and cancer: A previous study suggested that among men with a PSA doubling time (PSADT) < 9 months after the PSA increase, salvage androgen deprivation therapy was significantly associated with a decreased risk of all‐cause and cancer‐specific mortality in the prostatectomy and radiotherapy cohorts.5